In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-13 of 13 for your search:
Drug:  defined green tea catechin extract
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000454773, P30CA015083, MC0419, 1155-05, NCI-2009-01227, MAYO-MC0419, 7303, NCI-7303, CLLT-MAYO-MC0419, NCT00262743
2.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: H06-128, IND78,248, NCT00707252
3.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000377681, P30CA016042, UCLA-0301091-03, NCT00088946
4.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UARIZ-UAZ03-1-02, UARIZ-HSC-0540, UAZ03-1-02, NCT00303823
5.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: 40 to 80
Sponsor: NCI, Other
Protocol IDs: CDR0000487501, U01CA101204, P30CA023074, UARIZ-HSC-0353, NCT00363805
6.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 45 to 74
Sponsor: NCI, Other
Protocol IDs: CDR0000578191, P01CA096964, BCCA-H03-61083, BCCA-R03-1083, H03-61083, NCT00573885
7.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: H04-176, NCT00676780
8.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 21 to 75
Sponsor: Other
Protocol IDs: H04-179, NCT00676793
9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000646899, P30CA022453, WSU-2009-015, 2009-015, NCT00942422
10.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000538554, P30CA023074, UARIZ-UAZ05-6-01, UARIZ-HSC-06-0695-04, UAZ05-6-01, HSC# 06-0695-04, NCT00459407
11.

Phase: Phase I
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2004-0907, CDR0000429486, MDA-03101, MDA-2004-0907, CPMC-AAA0407, N01-CN-35159, NCT00233935
12.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention, Treatment
Status: Closed
Age: 21 to 65
Sponsor: NCI, Other
Protocol IDs: 2006-0521, MDA-MDA04-4-01, MDA-2006-0521, CPMC-IRB-AAAB7638, CDR0000557580, MDA04-4-01, NCT00516243
13.

Phase: Phase I
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000387801, P30CA023074, UARIZ-HSC-0499, NCT00091325
New Search